Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 32

1.

Prevalence and patterns of antipsychotic use in youth at the time of admission and discharge from an inpatient psychiatric facility.

Procyshyn RM, Su J, Elbe D, Liu AY, Panenka WJ, Davidson J, Honer WG, Barr AM.

J Clin Psychopharmacol. 2014 Feb;34(1):17-22. doi: 10.1097/JCP.0b013e3182a607dd.

PMID:
24346744
2.

Polypharmacy for schizophrenia.

Ballon J, Stroup TS.

Curr Opin Psychiatry. 2013 Mar;26(2):208-13. doi: 10.1097/YCO.0b013e32835d9efb. Review.

3.

Treatment and outcomes of an Australian cohort of outpatients with bipolar I or schizoaffective disorder over twenty-four months: implications for clinical practice.

Kulkarni J, Filia S, Berk L, Filia K, Dodd S, de Castella A, Brnabic AJ, Lowry AJ, Kelin K, Montgomery W, Fitzgerald PB, Berk M.

BMC Psychiatry. 2012 Dec 17;12:228. doi: 10.1186/1471-244X-12-228.

4.

Description of long-term polypharmacy among schizophrenia outpatients.

Suokas JT, Suvisaari JM, Haukka J, Korhonen P, Tiihonen J.

Soc Psychiatry Psychiatr Epidemiol. 2013 Apr;48(4):631-8. doi: 10.1007/s00127-012-0586-6. Epub 2012 Sep 25.

PMID:
23007295
5.
6.

Antipsychotic monotherapy and polypharmacy in the treatment of outpatients with schizophrenia in the European Schizophrenia Outpatient Health Outcomes Study.

Novick D, Ascher-Svanum H, Brugnoli R, Bertsch J, Hong J, Haro JM.

J Nerv Ment Dis. 2012 Jul;200(7):637-43. doi: 10.1097/NMD.0b013e31825bfd95.

PMID:
22759944
7.

Polypharmacy with antipsychotics, antidepressants, or benzodiazepines and mortality in schizophrenia.

Tiihonen J, Suokas JT, Suvisaari JM, Haukka J, Korhonen P.

Arch Gen Psychiatry. 2012 May;69(5):476-83. doi: 10.1001/archgenpsychiatry.2011.1532.

PMID:
22566579
8.

A case of quetiapine XR and divalproex-associated neutropenia followed by successful use of ziprasidone.

Estabrook KR, Pheister M.

J Clin Psychopharmacol. 2012 Jun;32(3):417-8. doi: 10.1097/JCP.0b013e318253a071. No abstract available.

PMID:
22561473
9.

Effects of polypharmacy on outcome in patients with schizophrenia in routine psychiatric treatment.

Längle G, Steinert T, Weiser P, Schepp W, Jaeger S, Pfiffner C, Frasch K, Eschweiler GW, Messer T, Croissant D, Becker T, Kilian R.

Acta Psychiatr Scand. 2012 May;125(5):372-81. doi: 10.1111/j.1600-0447.2012.01835.x. Epub 2012 Feb 9.

PMID:
22321029
10.
11.

Identification and management of in-hospital drug-induced delirium in older patients.

Catic AG.

Drugs Aging. 2011 Sep 1;28(9):737-48. doi: 10.2165/11592240-000000000-00000. Review.

PMID:
21913739
12.

How the medication review can help to reduce risk of falls in older patients.

Kelly DM, Frick EM, Hale LS.

JAAPA. 2011 Apr;24(4):30-4, 55. Review. No abstract available.

PMID:
21534380
14.

[Polypharmacy in schizophrenia].

Zink M, Englisch S, Meyer-Lindenberg A.

Nervenarzt. 2011 Jul;82(7):853-8. doi: 10.1007/s00115-010-3196-0. German.

PMID:
21165589
15.

A naturalistic study of changes in pharmacological prescription for borderline personality disorder in clinical practice: from APA to NICE guidelines.

Pascual JC, Martín-Blanco A, Soler J, Ferrer A, Tiana T, Alvarez E, Pérez V.

Int Clin Psychopharmacol. 2010 Nov;25(6):349-55. doi: 10.1097/YIC.0b013e32833e23ed.

PMID:
20838221
16.

Validity of the Finnish Prescription Register for measuring psychotropic drug exposures among elderly finns: a population-based intervention study.

Rikala M, Hartikainen S, Sulkava R, Korhonen MJ.

Drugs Aging. 2010 Apr 1;27(4):337-49. doi: 10.2165/11315960-000000000-00000.

PMID:
20359263
17.

Combined treatment with amisulpride in patients with schizophrenia discharged from a short-term hospitalization unit: a 1-year retrospective study.

Molina JD, Lerma-Carrillo I, Leonor M, Pascual F, Blasco-Fontecilla H, González-Parra S, López-Muñoz F, Alamo C.

Clin Neuropharmacol. 2009 Jan-Feb;32(1):10-5. doi: 10.1097/WNF.0B013E3181672213.

PMID:
18978498
18.

Comparing the use and discontinuation of antipsychotics in clinical practice: an observational study.

Taylor M, Shajahan P, Lawrie SM.

J Clin Psychiatry. 2008 Feb;69(2):240-5.

PMID:
18363452
19.

Fatal hyponatremia and other metabolic disturbances associated with psychotropic drug polypharmacy.

Vucicevic Z, Degoricija V, Alfirevic Z, Vukicevic-Badouin D.

Int J Clin Pharmacol Ther. 2007 May;45(5):289-92.

PMID:
17542351
20.

Somatic augmentation strategies in clozapine resistance--what facts?

Tranulis C, Mouaffak F, Chouchana L, Stip E, Gourevitch R, Poirier MF, Olié JP, Lôo H, Gourion D.

Clin Neuropharmacol. 2006 Jan-Feb;29(1):34-44. Review.

PMID:
16518133
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk